基于SEER数据库乳腺腺样囊性癌临床病理特征及预后分析
Clinicopathological Features and Prognosis of Adenoid Cystic Carcinoma of the Breast Based on SEER Database
摘要: 目的：探讨乳腺腺样囊性癌患者的临床病理特征、预后及相关影响因素。方法：从SEER数据库中提取2010年至2016年诊断为乳腺腺样囊性癌的148例女性患者的病例资料，回顾性分析其临床病理特征、生存情况及预后影响因素。结果：乳腺腺样囊性癌患者148例中，107例(72.3%)为三阴性乳腺癌，77例(52.0%)为组织学分级I级，80例(54.1%)为T1期，143例(96.6%)为N0期，148例(100.0%)为M0期，148例(100.0%)接受手术治疗，89例(60.1%)接受放疗，133例(89.9%)未进行化疗。单因素分析显示：年龄、原发灶部位、组织学分级、N分期、化疗与患者预后有关(P < 0.05)。多因素COX回归分析显示：年龄、组织学分级是影响病人预后的独立危险因素(P < 0.05)。结论：影响乳腺腺样囊性癌患者预后的独立危险因素是年龄、分级。放疗和化疗对乳腺腺样囊性癌患者的总生存率是否有益有待进一步研究探讨。
Abstract: Objective: To investigate the clinicopathological features, prognosis and related influencing factors of patients with adenoid cystic carcinoma of the breast. Methods: Case data of 148 female patients diagnosed with adenoid cystic carcinoma of the breast from 2010 to 2016 were extracted from the SEER database, the clinicopathological characteristics, survival and prognostic factors were retro-spectively analyzed. Results: Among 148 patients with adenoid cystic carcinoma of the breast, 107 cases (72.3%) were triple negative breast cancer, 77 cases (52.0%) were histological grade I, 80 cases (54.1%) were T1 stage, 143 cases (96.6%) were N0 stage, 148 cases (100.0%) was M0 stage, 148 cases (100.0%) received surgery, 89 cases (60.1%) received radiotherapy, and 133 cases (89.9%) did not receive chemotherapy. Univariate analysis showed that age, primary tumor site, histological grade, N stage and chemotherapy were related to the prognosis of patients (P < 0.05). Multivariate COX regression analysis showed that age and histological grade were independent risk factors affecting the prognosis of patients (P < 0.05). Conclusion: The independent risk factors af-fecting the prognosis of patients with adenoid cystic carcinoma of the breast are age and grade. Whether radiotherapy and chemotherapy are beneficial to the overall survival of patients with ad-enoid cystic carcinoma of the breast remains to be further investigated.
文章引用：陈丹, 周雅静, 李建辉. 基于SEER数据库乳腺腺样囊性癌临床病理特征及预后分析[J]. 临床医学进展, 2022, 12(8): 7919-7926. https://doi.org/10.12677/ACM.2022.1281141

参考文献

[1] Annette, L. (2021) Updated WHO Classification of Tumors of the Breast. Pathologe, 42, 155-159. [Google Scholar] [CrossRef] [PubMed]
[2] Coates, J.M., Martinez, S.R., Bold, R.J. and Chen, S.L. (2010) Adjuvant Radiation Therapy Is Associated with Improved Survival for Adenoid Cystic Carcinoma of the Breast. Journal of Surgical Oncology, 102, 342-347. [Google Scholar] [CrossRef] [PubMed]
[3] Li, N., Xu, L., Zhao, H., El-Naggar, A.K. and Sturgis, E.M. (2012) A Comparison of the Demographics, Clinical Features, and Survival of Patients with Adenoid Cystic Carcinoma of Major and Minor Salivary Glands versus Less Common Sites within the Surveillance, Epidemiology, and End Results Registry. Cancer, 118, 3945-3953. [Google Scholar] [CrossRef] [PubMed]
[4] Glazebrook, K.N., Reynolds, C., Smith, R.L., Gimenez, E.I. and Boughey, J.C. (2010) Adenoid Cystic Carcinoma of the Breast. American Journal of Roentgenology, 194, 1391-1396. [Google Scholar] [CrossRef] 
[5] Pang, W., Wang, Z., Jin, X. and Zhang, Q. (2019) Adenoid Cystic Car-cinoma of the Breast in a Male: A Case Report. Medicine, 98, Article ID: e16760. [Google Scholar] [CrossRef] 
[6] Treitl, D., Radkani, P., Rizer, M., El Hussein, S., Paramo, J.C. and Mesko, T.W. (2018) Adenoid Cystic Carcinoma of the Breast, 20 Years of Experience in a Single Center with Review of Literature. Breast Cancer, 25, 28-33. [Google Scholar] [CrossRef] [PubMed]
[7] Zhang, W., Fang, Y., Zhang, Z. and Wang, J. (2021) Management of Adenoid Cystic Carcinoma of the Breast: A Single-Institution Study. Frontiers in Oncology, 11, Article ID: 621012. [Google Scholar] [CrossRef] [PubMed]
[8] Defaud-Hénon, F., Tunon-de-Lara, C., Fournier, M., Marty, M., Velasco, V., de Mascarel, I., et al. (2010) Adenoid Cystic Carcinoma of the Breast: Clinical, Histological and Immuno-histochemical Characterization. Annales de Pathologie, 30, 7-16. [Google Scholar] [CrossRef] [PubMed]
[9] Schnitt, S.J. and Collins, L.C. (2014) Biopsy Interpretation of the Breast. Xue, D.B., Huang, W.B., Translate. Second Edition, Beijing Science Press, Beijing, 279-283.
[10] Arpino, G., Clark, G.M., Mohsin, S., Bardou, V.J. and Elledge, R.M. (2002) Adenoid Cystic Carcinoma of the Breast: Molecular Markers, Treatment, and Clinical Outcome. Cancer, 94, 2119-2127. [Google Scholar] [CrossRef] [PubMed]
[11] Sanges, F., Floris, M., Cossu-Rocca, P., Muroni, M.R., Pira, G., Urru, S.A.M., et al. (2020) Histologic Subtyping Affecting Outcome of Triple Negative Breast Cancer: A Large Sardinian Population-Based Analysis. BMC Cancer, 20, Article No. 491. [Google Scholar] [CrossRef] [PubMed]
[12] Thompson, K., Grabowski, J., Saltzstein, S.L., Sadler, G.R. and Blair, S.L. (2011) Adenoid Cystic Breast Carcinoma: Is Axillary Staging Necessary in all Cases? Results from the Cali-fornia Cancer Registry. The Breast Journal, 17, 485-489. [Google Scholar] [CrossRef] [PubMed]
[13] Ro, J.Y., Mackay, B., Batsakis, J.G. and Cartwright, J. (1987) Intraluminal Crystalloids in Malignant Salivary Gland Tumors (Electron Microscopic and X-Ray Microanalytic Studies). The Journal of Laryngology and Otology, 101, 1175-1181. [Google Scholar] [CrossRef] 
[14] Shin, S.J. and Rosen, P.P. (2002) Solid Variant of Mammary Adenoid Cystic Carcinoma with Basaloid Features: A Study of Nine Cases. The American Journal of Surgical Pathology, 26, 413-420. [Google Scholar] [CrossRef] [PubMed]
[15] Khanfir, K., Kallel, A., Villette, S., Belkacémi, Y., Vau-travers, C., Nguyen, T., et al. (2012) Management of Adenoid Cystic Carcinoma of the Breast: A Rare Cancer Network Study. International Journal of Radiation Oncology, Biology, Physics, 82, 2118-2124. [Google Scholar] [CrossRef] [PubMed]
[16] Sun, J.-Y., Wu, S.-G., Chen, S.-Y., Li, F.Y., Lin, H.X., Chen, Y.X., et al. (2017) Adjuvant Radiation Therapy and Survival for Adenoid Cystic Carcinoma of the Breast. Breast, 31, 214-218. [Google Scholar] [CrossRef] [PubMed]
[17] Miyai, K., Schwartz, M.R., Divatia, M.K., Anton, R.C., Park, Y.W., Ayala, A.G., et al. (2014) Adenoid Cystic Carcinoma of Breast: Recent Advances. World Journal of Clinical Cases, 2, 732-741. [Google Scholar] [CrossRef] [PubMed]
[18] Guo, S.P., Li, Q.L., Wang, Y.M., Zeng, K.X., Liu, Y., Xu, W.N., et al. (2017) Clinicopathologic Features of Adenoid Cystic Carcinoma of Breast. Chinese Journal of Pathology, 46, 25-29. (In Chinese)
[19] Vranic, S., Frkovic-Grazio, S., Lamovec, J., Serdarevic, F., Gurjeva, O., Palazzo, J., et al. (2010) Adenoid Cystic Carcinomas of the Breast Have Low Topo IIα Expression but Frequently Overexpress EGFR Protein without EGFR Gene Amplification. Human Pathology, 41, 1617-1623. [Google Scholar] [CrossRef] [PubMed]

为你推荐